DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,553,034 | +28.5% | 14,221 | +28.5% | 0.09% | +28.8% |
Q1 2024 | $2,764,601 | +9.8% | 11,071 | +1.7% | 0.07% | -11.0% |
Q4 2023 | $2,518,936 | -6.4% | 10,888 | +0.4% | 0.08% | -18.0% |
Q3 2023 | $2,689,938 | +4.0% | 10,842 | +0.6% | 0.10% | +2.0% |
Q2 2023 | $2,585,825 | -6.1% | 10,774 | -1.4% | 0.10% | -14.8% |
Q1 2023 | $2,752,681 | -5.0% | 10,922 | +0.1% | 0.12% | -17.3% |
Q4 2022 | $2,896,712 | +27.2% | 10,914 | +23.8% | 0.14% | +14.9% |
Q3 2022 | $2,278,000 | +3.4% | 8,818 | +1.4% | 0.12% | +4.3% |
Q2 2022 | $2,204,000 | -11.9% | 8,695 | +1.9% | 0.12% | 0.0% |
Q1 2022 | $2,503,000 | -12.8% | 8,533 | -2.1% | 0.12% | -10.1% |
Q4 2021 | $2,869,000 | +5.3% | 8,720 | -2.6% | 0.13% | -7.2% |
Q3 2021 | $2,724,000 | +15.0% | 8,949 | +1.4% | 0.14% | +10.3% |
Q2 2021 | $2,368,000 | +14.1% | 8,822 | -4.3% | 0.13% | +5.0% |
Q1 2021 | $2,075,000 | +4.0% | 9,219 | +2.6% | 0.12% | -4.0% |
Q4 2020 | $1,996,000 | -2.8% | 8,985 | -5.8% | 0.12% | -18.8% |
Q3 2020 | $2,053,000 | +20.3% | 9,535 | -1.2% | 0.15% | +4.8% |
Q2 2020 | $1,706,000 | +27.1% | 9,650 | -0.4% | 0.15% | -0.7% |
Q1 2020 | $1,342,000 | -16.8% | 9,692 | -7.8% | 0.15% | -4.5% |
Q4 2019 | $1,613,000 | +5.5% | 10,508 | -0.8% | 0.16% | -4.9% |
Q3 2019 | $1,529,000 | +1.2% | 10,588 | +0.1% | 0.16% | -3.6% |
Q2 2019 | $1,511,000 | +8.6% | 10,574 | +0.3% | 0.17% | +5.0% |
Q1 2019 | $1,391,000 | +34.8% | 10,540 | +5.3% | 0.16% | +19.3% |
Q4 2018 | $1,032,000 | -17.9% | 10,010 | -13.5% | 0.14% | -18.2% |
Q3 2018 | $1,257,000 | +10.2% | 11,570 | +0.1% | 0.16% | -1.8% |
Q2 2018 | $1,141,000 | +1.0% | 11,558 | +0.1% | 0.17% | -7.7% |
Q1 2018 | $1,130,000 | +5.4% | 11,546 | 0.0% | 0.18% | -1.1% |
Q4 2017 | $1,072,000 | +17.7% | 11,546 | +8.7% | 0.18% | +10.2% |
Q3 2017 | $911,000 | +1.6% | 10,626 | 0.0% | 0.17% | -1.8% |
Q2 2017 | $897,000 | -1.3% | 10,626 | 0.0% | 0.17% | -4.0% |
Q1 2017 | $909,000 | +9.9% | 10,626 | 0.0% | 0.18% | +7.3% |
Q4 2016 | $827,000 | – | 10,626 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |